CCO Oncology Podcast

En podkast av Clinical Care Options

Kategorier:

189 Episoder

  1. Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions

    Publisert: 31.1.2022
  2. Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease

    Publisert: 26.1.2022
  3. Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

    Publisert: 14.1.2022
  4. Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

    Publisert: 10.1.2022
  5. Strategies for Secondary AML and Emerging Therapies for AML

    Publisert: 10.1.2022
  6. Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

    Publisert: 10.1.2022
  7. An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    Publisert: 10.1.2022
  8. Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    Publisert: 22.12.2021
  9. Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    Publisert: 22.12.2021
  10. Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer

    Publisert: 17.12.2021
  11. The Evolving Role of TKIs in First-line Treatment of Advanced HCC

    Publisert: 14.12.2021
  12. Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

    Publisert: 23.11.2021
  13. Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer

    Publisert: 23.11.2021
  14. Overcoming Acquired Resistance With Second-Generation TRK Inhibitors

    Publisert: 9.11.2021
  15. Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

    Publisert: 2.11.2021
  16. PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

    Publisert: 26.10.2021
  17. Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Publisert: 21.10.2021
  18. First-Generation TRK Inhibitors: Clinical Evidence and Indications

    Publisert: 15.10.2021
  19. PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

    Publisert: 14.10.2021
  20. Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

    Publisert: 8.10.2021

5 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site